|
ST7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.722300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.918200E-02 |
| Normal-vs-Stage2 |
4.604800E-01 |
| Normal-vs-Stage3 |
9.507900E-02 |
| Normal-vs-Stage4 |
9.100400E-02 |
| Stage1-vs-Stage2 |
9.324000E-01 |
| Stage1-vs-Stage3 |
5.858800E-01 |
| Stage1-vs-Stage4 |
6.321600E-01 |
| Stage2-vs-Stage3 |
6.822600E-01 |
| Stage2-vs-Stage4 |
6.997400E-01 |
| Stage3-vs-Stage4 |
9.160200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.035600E-02 |
| Normal-vs-AfricanAmerican |
9.281000E-01 |
| Normal-vs-Asian |
5.703600E-02 |
| Caucasian-vs-AfricanAmerican |
1.326430E-01 |
| Caucasian-vs-Asian |
4.930800E-01 |
| AfricanAmerican-vs-Asian |
3.312200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.158400E-02 |
| Normal-vs-Female |
2.286800E-01 |
| Male-vs-Female |
8.092400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.473030E-01 |
| Normal-vs-Extreme_Weight |
7.507800E-02 |
| Normal-vs-Obese |
2.268600E-01 |
| Normal-vs-Extreme_Obese |
5.077200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.976200E-01 |
| Normal_Weight-vs-Obese |
5.811800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.829200E-01 |
| Extreme_Weight-vs-Obese |
6.636000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.479800E-01 |
| Obese-vs-Extreme_Obese |
9.739800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.799200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.992200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.502800E-03 |
| Normal-vs-Age(81-100Yrs) |
8.280600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.300600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.930600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.744400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.109600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.488400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.414230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.685800E-01 |
| Normal-VS-Type2 PRCC |
2.014400E-01 |
| Normal-VS-KIRP CIMP |
2.05289999999358E-05 |
| Normal-VS-Unclassified PRCC |
6.901500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.579800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.303200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.000600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.862380E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.048200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.163900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.481900E-02 |
| Normal-vs-N1 |
2.606800E-01 |
| Normal-vs-N2 |
5.422700E-03 |
| N0-vs-N1 |
8.963000E-01 |
| N0-vs-N2 |
2.043400E-01 |
| N1-vs-N2 |
3.789200E-01 |
|
|
